Citation: | QI Xiaowei, JIN Linfang, PU Yong, FENG Jingjie, LIU Yankui, HUA Dong. Expression of CXCR5, CXCL13, MMP-12 and MMP-13 in Colorectal Cancer and Their Significance[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 159-163. DOI: 10.3971/j.issn.1000-8578.2015.02.013 |
[1] |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
|
[2] |
Markowitz SD, Dawson DM, Willis J, et al. Focus on colon cancer[J]. Cancer Cell, 2002, 1(3): 233-6.
|
[3] |
Labianca R, Nordlinger B, Beretta GD, et al. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up[J]. Ann Oncol, 2010, 21 Suppl 5: v70-7.
|
[4] |
Franciszkiewicz K, Boissonnas A, Boutet M, et al. Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response[J]. Cancer Res, 2012, 72 (24): 6325-32.
|
[5] |
Kataoka H, Tanaka H, Nagaike K, et al. Role of cancer cell-stroma interaction in invasive growth of cancer cells[J]. Hum Cell, 2003, 16 (1): 1-14.
|
[6] |
Müller G, Höpken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity[J]. Immunol Rev, 2003, 195: 117-35.
|
[7] |
Bürkle A, Niedermeier M,Schmitt-Gräff A, et al. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia[J]. Blood, 2007, 110(9): 3316-25.
|
[8] |
Meijer J, Zeelenberg IS, Sipos B, et al. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver[J]. Cancer Res, 2006, 66(19): 95 76-82.
|
[9] |
Freije JM, Díez-Itza I, Balbín M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas[J]. J Biol Chem,1994, 269(24): 16766-73.
|
[10] |
Mori M, Barnard GF, Mimori K, et al. Overpression of matri x metalloproteinase-7 mRNA in human colon carcinomas[J]. Cancer, 1995, 75(6 Suppl): 1516-9.
|
[11] |
VAN Nguyen S, Skarstedt M, Löfgren S, et al. Gene polymorphism of matrix metalloproteinase-12 and -13 and association with colorectal cancer in Swedish patients[J]. Anticancer Res, 2013, 33 (8): 3247-50.
|
[12] |
Razis E, Kalogeras KT, Kotoula V, et al. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13- CXCR5 messenger RNA expression[J]. Clin Breast Cancer, 2012, 12 (3): 183-93.
|
[13] |
Rath T, Stöckle J, Roderfeld M, et al. Matrix metalloproteinase- 13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration[J]. Oncol Lett, 2011, 2(3): 483-8.
|